Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis w...
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement
About this item
Full title
Author / Creator
Publisher
Cham: Springer International Publishing
Journal title
Language
English
Formats
Publication information
Publisher
Cham: Springer International Publishing
Subjects
More information
Scope and Contents
Contents
Objectives
To determine the effectiveness of golimumab (GLM) in improving joint, periarticular structures and cutaneous manifestations in patients with moderate to severe psoriatic arthritis (PsA) with cutaneous psoriasis in different real-life clinical settings and 48-month drug survival.
Methods
Clinical and laboratory records were colle...
Alternative Titles
Full title
Long-term effectiveness and drug survival of golimumab in patients affected by psoriatic arthritis with cutaneous involvement
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8724144
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8724144
Other Identifiers
ISSN
0770-3198
E-ISSN
1434-9949
DOI
10.1007/s10067-021-05874-6
